AMPK激活是食道腺癌细胞中常见的支持生存途径
Niamh McNamee1, Pavithra Rajagopalan1, Aya Tal-Mason1
1Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
Biomolecules
|September 28, 2024
概括
在治疗期间,AMP激活蛋白激酶 (AMPK) 促进食道腺癌 (EAC) 细胞的存活. 抑制AMPK增强细胞死亡,建议它作为改善EAC治疗疗效的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 食道腺癌 (EAC) 的生存率很低,并且经常复发.
- 对于EAC对化疗和辐射耐药性的机制仍然不太清楚.
研究的目的:
- 调查AMP激活蛋白激酶 (AMPK) 在EAC治疗耐药性中的作用.
- 探索AMPK作为EAC的潜在治疗点.
主要方法:
- 使用的OE33 EAC细胞系和人类患者衍生的EAC器官.
- 服用IL-6抑制剂 (托西利祖马布),西斯,电离辐射和AMPK抑制剂 (化合物C).
- 进行了AMPK表达的基因淘汰.
主要成果:
- 在EAC细胞中观察到AMPK激活,这些细胞在接受托西利祖马布,西斯普拉丁或电离辐射治疗时被激活.
- AMPK激活导致MTORC1信号减少和氧化性线粒体代谢增加,促进细胞存活.
- 抑制或淘汰AMPK协同增强的细胞死亡,由化疗或辐射诱导.
结论:
- AMPK作为一种促生存机制,在EAC中产生治疗耐药性.
- 向AMPK可能会提高当前和未来EAC治疗策略的有效性.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K


